Literature DB >> 22223743

The impact of polypharmacy on the health of Canadian seniors.

Ben Reason1, Michael Terner, Ali Moses McKeag, Brenda Tipper, Greg Webster.   

Abstract

BACKGROUND: Prescription medication use increases with age. Seniors face an increased risk of adverse drug reactions from medications, partly because the kidneys and liver can lose functional ability with increasing age, resulting in the need for changes in dosage.
OBJECTIVE: To use population survey data to understand the extent and impact of multiple medication use and adverse drug events among Canadian seniors.
METHODS: This study consists of analysis of data from the Canadian Survey of Experiences with Primary Health Care, which was conducted through telephone by Statistics Canada in 2008. These analyses focussed on the 3132 respondents who were ≥ 65 years of age.
RESULTS: Twenty-seven per cent of seniors reported taking five or more medications on a regular basis. Within the past year, 12% of seniors taking five or more medications experienced a side effect that required medical attention compared with 5% of seniors taking only one or two medications. Even when controlling for age and number of chronic conditions, the number of prescription medications was associated with the rate of emergency department use. Less than half of all seniors reported having received medication reviews and having the possible side effects of their prescription medications explained to them by their physician.
CONCLUSIONS: Many Canadian seniors have an elevated risk of adverse events due to taking a high number of prescription medications and not having the potential side effects and drug interactions explained to them. There are interventions that can potentially reduce polypharmacy and adverse events, including routine medication reviews.

Mesh:

Year:  2012        PMID: 22223743     DOI: 10.1093/fampra/cmr124

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  35 in total

1.  Identification of inappropriate medication use in elderly patients with frequent emergency department visits.

Authors:  Jeffrey Wong; Patricia Marr; Debbie Kwan; Soumia Meiyappan; Lesley Adcock
Journal:  Can Pharm J (Ott)       Date:  2014-07

2.  The expanding scope of pharmacists' practice: implications for physicians.

Authors:  Cara Tannenbaum; Ross T Tsuyuki
Journal:  CMAJ       Date:  2013-08-19       Impact factor: 8.262

3.  Information for physicians and pharmacists about drugs that might cause dry mouth: a study of monographs and published literature.

Authors:  Caroline T Nguyen; Michael I MacEntee; Barbara Mintzes; Thomas L Perry
Journal:  Drugs Aging       Date:  2014-01       Impact factor: 3.923

4.  Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.

Authors:  Barbara Farrell; Kevin Pottie; Wade Thompson; Taline Boghossian; Lisa Pizzola; Farah Joy Rashid; Carlos Rojas-Fernandez; Kate Walsh; Vivian Welch; Paul Moayyedi
Journal:  Can Fam Physician       Date:  2017-05       Impact factor: 3.275

5.  Deprescribing: a new word to guide medication review.

Authors:  Christopher Frank
Journal:  CMAJ       Date:  2014-03-17       Impact factor: 8.262

6.  Educational needs, practice patterns and quality indicators to improve geriatric pharmacy care.

Authors:  Dan Zou; Cara Tannenbaum
Journal:  Can Pharm J (Ott)       Date:  2014-03

7.  The legibility of prescription medication labelling in Canada: Moving from pharmacy-centred to patient-centred labels.

Authors:  Susan J Leat; Kristina Ahrens; Abinaya Krishnamoorthy; Deborah Gold; Carlos H Rojas-Fernandez
Journal:  Can Pharm J (Ott)       Date:  2014-05

8.  Multimorbidity, polypharmacy and primary prevention in community-dwelling adults in Quebec: a cross-sectional study.

Authors:  Tu N Nguyen; Patrice Ngangue; Jeannie Haggerty; Tarek Bouhali; Martin Fortin
Journal:  Fam Pract       Date:  2019-11-18       Impact factor: 2.267

9.  Should Hospital Admission Be Used as an Opportunity for Deprescribing in Older Adults?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2020-10-01

10.  Polypharmacy and Renal Failure in Nursing Home Residents: Results of the Inappropriate Medication in Patients with Renal Insufficiency in Nursing Homes (IMREN) Study.

Authors:  Michael Dörks; Stefan Herget-Rosenthal; Guido Schmiemann; Falk Hoffmann
Journal:  Drugs Aging       Date:  2016-01       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.